Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic Efficacy
- Authors
- Jang, Myoung Jin; You, Dalsan; Park, Jin Young; Kim, Kyung; Aum, Joomin; Lee, Chunwoo; Song, Geehyun; Shin, Ha Chul; Suh, Nayoung; Kim, Yong Man; Kim, Choung-Soo
- Issue Date
- Nov-2018
- Publisher
- Korean Society for Stem Cell Research
- Keywords
- Ischemia-reperfusion injury; Acute kidney injury; Hypoxia preconditioning; Cell therapy; Renal function
- Citation
- International Journal of Stem Cells, v.11, no.2, pp 157 - +
- Journal Title
- International Journal of Stem Cells
- Volume
- 11
- Number
- 2
- Start Page
- 157
- End Page
- +
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5519
- DOI
- 10.15283/ijsc18073
- ISSN
- 2005-3606
2005-5447
- Abstract
- Although previous and ongoing clinical studies have used stromal cells during renal ischemia-reperfusion injury (IRI), there is little consensus regarding the optimal protocol. We aimed to optimize the protocol for hypoxic preconditioned human bone marrow-derived mesenchymal stromal cell (HP-hBMSC) therapy in a rat model of renal IRI. We determined the optimal injection route (renal arterial, renal parenchymal, and tail venous injection), dose (low-dose: 1x10(6), moderate-dose: 2x10(6), and high-dose: 4x10(6)), and injection period (pre-, concurrent-, and post-IRI). During optimal injection route study, renal arterial injections significantly reduced the decreasing glomerular filtration rate (GFR), as compared to GFRs for the IRI control group, 2 and 4 days after IRI. Therapeutic effects and histological recoveries were the greatest in the group receiving renal arterial injections. During the dose finding study, high-dose injections significantly reduced the decreasing GFR, as compared to GFRs for the IRI control group, 3 days after IRI. Therapeutic effects and histological recoveries were the greatest in the high-dose injection group. While determining the optimal injection timing study, concurrent-IRI injection reduced elevated serum creatinine levels, as compared to those of the IRI control group, 1 day after IRI. Pre-IRI injection significantly reduced the decreasing GFR, as compared with GFRs for the IRI control group, 1 day after IRI. Therapeutic effects and histological recoveries were the greatest in the concurrent-IRI group. In conclusion, the concurrent-IRI administration of a high dose of HP-hBMSC via the renal artery leads to an optimal recovery of renal function after renal IRI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medical Sciences > Department of Pharmaceutical Engineering > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.